Search

everythinglearnresearchcommunity

for

Search:↓

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Si Jun Zi Tang may slow aging by affecting specific cell signaling pathways.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Researchers found four genes that could help diagnose severe alopecia areata early.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Erdr1 could be a new marker for diagnosing hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Pantethine may boost the immune system's ability to fight sarcoma.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

New research is helping develop better treatments for alopecia areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Cannabinoids may help treat various skin conditions.

NK cells play a role in skin diseases like eczema and psoriasis.